Brain natriuretic peptide in the diagnosis and management of congestive heart failure

被引：2

作者：

Trinity, E ^{[1
]}

Apple, FS

机构：

[1] Hennepin Cty Med Ctr, Dept Lab Med & Pathol, Minneapolis, MN 55415 USA

[2] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA

来源：

LABORATORY MEDICINE | 2002年 / 33卷 / 10期

关键词：

D O I：

10.1309/WJGU-73JC-3LW0-6KRR

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Cardiac patients with a slightly increased brain natriuretic peptide (BNP) concentration have dramatically decreased survival rates as compared to patients with normal BNP. Laboratory tests for BNP help identify patients who are at greatest risk for heart failure, and therefore, require more aggressive therapy. Brain natriuretic peptide detection using a point-of-care platform makes testing accessible to more health care providers and multicenter trials easier to initiate.

引用

页码：793 / 796

页数：4

共 18 条

[1]

[Anonymous], [No title captured]

[2] Predictors of prognosis in patients with stable mild to moderate heart failure [J].

Bettencourt, P ;

Ferreira, A ;

Dias, P ;

Pimenta, J ;

Frioes, F ;

Martins, L ;

Cerqueira-Gomes, M .

JOURNAL OF CARDIAC FAILURE, 2000, 6 (04) :306-313

[3] Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting [J].

Dao, Q ;

Krishnaswamy, P ;

Kazanegra, R ;

Harrison, A ;

Amirnovin, R ;

Lenert, L ;

Clopton, P ;

Alberto, J ;

Hlavin, P ;

Maisel, AS .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) :379-385

[4] Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction [J].

Hammerer-Lercher, A ;

Neubauer, E ;

Müller, S ;

Pachinger, O ;

Puschendorf, B ;

Mair, J .

CLINICA CHIMICA ACTA, 2001, 310 (02) :193-197

[5] High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure [J].

Maeda, K ;

Tsutamoto, T ;

Wada, A ;

Mabuchi, N ;

Hayashi, M ;

Tsutsui, T ;

Ohnishi, M ;

Sawaki, M ;

Fujii, M ;

Matsumoto, T ;

Kinoshita, M .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (05) :1587-1593

[6] The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure [J].

Mair, J ;

Hammerer-Lercher, A ;

Puschendorf, B .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2001, 39 (07) :571-588

[7] Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure [J].

Maisel, AS ;

Krishnaswamy, P ;

Nowak, RM ;

McCord, J ;

Hollander, JE ;

Duc, P ;

Omland, T ;

Storrow, AB ;

Abraham, WT ;

Wu, AHB ;

Clopton, P ;

Steg, PG ;

Westheim, A ;

Knudsen, CW ;

Perez, A ;

Kazanegra, R ;

Herrmann, HC ;

McCullough, PA .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (03) :161-167

[8] Practical approaches to treating patients with acute decompensated heart failure [J].

Maisel, AS .

JOURNAL OF CARDIAC FAILURE, 2001, 7 (02) :13-17

[9]

MAISEL AS, 2002, PRINCIPLES PRACTICE, P554

[10] Biochemical detection of left-ventricular systolic dysfunction [J].

McDonagh, TA ;

Robb, SD ;

Murdoch, DR ;

Morton, JJ ;

Ford, I ;

Morrison, CE ;

Tunstall-Pedoe, H ;

McMurray, JJV ;

Dargie, HJ .

LANCET, 1998, 351 (9095) :9-13

← 1 2 →